Article Information
History
- October 12, 2022.
Article Versions
- Version 1 (October 8, 2022 - 15:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Åshild Ø. Solvin1,*,
- Vera V. Bjarkø1,2,
- Laurent F. Thomas1,3,4,
- Patricia Berrospi1,
- Kristian Hveem1,5,
- Marit Saunes6,
- Bjørn O. Åsvold1,2,5 and
- Mari Løset1,6
- 1K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway
- 2Department of Endocrinology, Clinic of Medicine, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
- 3Department of Clinical and Molecular Medicine, NTNU - Norwegian University of Science and Technology, Trondheim, Norway
- 4BioCore - Bioinformatics Core Facility, NTNU - Norwegian University of Science and Technology, Trondheim, Norway
- 5HUNT Research Centre, Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Levanger, Norway
- 6Department of Dermatology, Clinic of Orthopedics, Rheumatology and Dermatology, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
- ↵*Corresponding author:
Åshild Øksnevad Solvin, MD, K. G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway, Postboks 8905, N-7491 Trondheim, Norway, Tel: +47 480 49 610, Email: ashild.o.solvin{at}ntnu.no
Posted October 12, 2022.
Body Composition, Cardiometabolic Risk Factors and Comorbidities in Psoriasis and the Effect of HLA-C*06:02 Status: The HUNT Study, Norway
